Doravirine plus lamivudine two-drug regimen as maintenance antiretroviral therapy in people living with HIV: a French observational study.

Pascale PerfezouNolwenn HallJean-Charles DutheBasma AbdiSophie SeangCédric ArvieuxIsabelle LamauryAmélie MenardAnne-Geneviève MarcelinChristine KatlamaRomain Palichnull null

Published in: The Journal of antimicrobial chemotherapy (2023)

These preliminary findings suggest that doravirine/lamivudine regimens can maintain high levels of viral suppression in highly ART-experienced PLWH with long-term viral suppression, and good CD4+ T cell count.

Keyphrases

antiretroviral therapy
hiv infected patients
hiv infected
human immunodeficiency virus
sars cov
hiv positive
hiv aids
peripheral blood
adverse drug